KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 64 filers reported holding KALA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -33.3% | 10,192 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -80.0% | 10,192 | -10.5% | 0.00% | – |
Q1 2022 | $15,000 | +15.4% | 11,392 | 0.0% | 0.00% | – |
Q4 2021 | $13,000 | -61.8% | 11,392 | -12.2% | 0.00% | – |
Q3 2021 | $34,000 | -54.7% | 12,980 | -9.4% | 0.00% | – |
Q2 2021 | $75,000 | -14.8% | 14,321 | +8.8% | 0.00% | – |
Q1 2021 | $88,000 | -26.7% | 13,166 | -26.2% | 0.00% | – |
Q4 2020 | $120,000 | +26.3% | 17,841 | +39.4% | 0.00% | – |
Q3 2020 | $95,000 | -29.1% | 12,797 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $134,000 | +34.0% | 12,797 | +12.3% | 0.00% | – |
Q1 2020 | $100,000 | +138.1% | 11,397 | 0.0% | 0.00% | – |
Q4 2019 | $42,000 | +2.4% | 11,397 | +4.4% | 0.00% | – |
Q3 2019 | $41,000 | -40.6% | 10,913 | 0.0% | 0.00% | – |
Q2 2019 | $69,000 | -23.3% | 10,913 | 0.0% | 0.00% | – |
Q1 2019 | $90,000 | +76.5% | 10,913 | +4.6% | 0.00% | – |
Q4 2018 | $51,000 | -61.7% | 10,437 | -22.7% | 0.00% | -100.0% |
Q3 2018 | $133,000 | -28.1% | 13,501 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $185,000 | -13.1% | 13,501 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $213,000 | -22.0% | 13,501 | -8.5% | 0.00% | 0.0% |
Q4 2017 | $273,000 | – | 14,751 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 1,704,849 | $9,036,000 | 6.19% |
RA Capital Management | 10,874,613 | $57,635,000 | 0.92% |
Mesirow Financial Investment Management, Inc. | 42,104 | $223,000 | 0.57% |
ACT CAPITAL MANAGEMENT, LLC | 190,000 | $1,007,000 | 0.52% |
Samsara BioCapital, LLC | 601,162 | $3,186,000 | 0.39% |
Orbimed Advisors | 5,465,030 | $28,965,000 | 0.29% |
ALGERT GLOBAL LLC | 72,490 | $384,000 | 0.13% |
Knights of Columbus Asset Advisors LLC | 236,257 | $1,252,000 | 0.12% |
Bridgefront Capital, LLC | 47,569 | $252,000 | 0.10% |
Matisse Capital | 56,100 | $297,000 | 0.09% |